NCT02059070View on ClinicalTrials.gov

Bupivacaine Versus Ropivacaine on Diaphragmatic Motility and Ventilatory Function

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

June 30, 2013

Conditions
Paresis
Interventions
DRUG

Ropivacaine

Post-operative epidural 0.125% Ropivacaine Interscalene brachial plexus block, 20-28 hrs post surgery.

DRUG

Bupivacaine

Post-operative epidural 0.125% Bupivacaine Interscalene brachial plexus block, 20-28 hrs post surgery.

Trial Locations (1)

48071

DMC Surgery Hospital, Madison Heights

All Listed Sponsors
collaborator

Wayne State University

OTHER

lead

Anesthesiology WSU/DMC-NorthStar

OTHER

NCT02059070 - Bupivacaine Versus Ropivacaine on Diaphragmatic Motility and Ventilatory Function | Biotech Hunter | Biotech Hunter